Received Jan 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Suspected vaccination failure; I had shingles in spite of vaccine; Grover's Disease; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: I had shingles in spite of vaccine) and grover's disease (Verbatim: Grover's Disease). The outcome of the vaccination failure and shingles were not reported and the outcome of the grover's disease was not resolved. It was unknown if the reporter considered the vaccination failure, shingles and grover's disease to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles and grover's disease to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 26-DEC-2025 This case was reported by a patient via interactive digital media. The patient had shingles in spite of vaccine, a bad case, and now had grover's disease, which was finding very difficult to manage. The reporter was asking could that be related to shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The batch number was not provided and we and unable to contact the reporter.; Sender's Comments: A case of Vaccination failure, unknown time after receiving Shingles vaccine, in a patient. Based on the available information a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.